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Abstract
Background: With the advent of sequence-based approaches in the mutagenesis studies, it is now
possible to directly evaluate the genome-wide pattern of experimentally induced DNA sequence
changes for a diverse array of organisms. To gain a more comprehensive understanding of the
mutational bias inherent in mouse ENU mutagenesis, this study describes a detailed evaluation of
the induced mutational pattern obtained from a sequence-based screen of ENU-mutagenized mice.
Results: Based on a large-scale screening data, we derive the sequence-based estimates of the
nucleotide-specific pattern and frequency of ENU-induced base replacement mutation in the mouse
germline, which are then combined with the pattern of codon usage in the mouse coding sequences
to infer the spectrum of amino acid changes obtained by ENU mutagenesis. We detect a statistically
significant difference between the mutational patterns in phenotype- versus sequence-based
screens, which presumably reflects differential phenotypic effects caused by different amino acid
replacements. We also demonstrate that the mutations exhibit strong strand asymmetry, and that
this imbalance is generated by transcription, most likely as a by-product of transcription-coupled
DNA repair in the germline.
Conclusion: The results clearly illustrate the biased nature of ENU-induced mutations. We expect
that a precise understanding of the mutational pattern and frequency of induced nucleotide changes
would be of practical importance when designing sequence-based screening strategies to generate
mutant mouse strains harboring amino acid variants at specific loci. More generally, by enhancing
the collection of experimentally induced mutations in unambiguously defined genomic regions,
sequence-based mutagenesis studies will further illuminate the molecular basis of mutagenic and
repair mechanisms that preferentially produce a certain class of mutational changes over others.
Background
In the post-sequencing era of genome biology, the main
focus of interest has shifted from questions of genome
structure to problems of gene function. Many research
activities are now directed towards establishing precise
understanding of genetic architecture underlying pheno-
typic variation. Recently, chemical mutagenesis has
become a major method of promoting functional analysis
of the mouse genome. N-ethyl-N-nitrosourea (ENU) is
known to generate a spectrum of alleles, mainly by intro-
ducing single base replacement changes (i.e. transitions
and transversions), and has been the mutagen of choice
for enhancing the genetic resource for biomedical applica-
tions [1,2].
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in recovering mutations of interest. One criticism con-
cerning the utility of ENU mutagenesis is that it may not
be an efficient way of producing appropriate models of
naturally occurring genetic variants (such as human
genetic disorders) [3]. Indeed, ENU-induced nucleotide
changes are known to exhibit a strong bias towards partic-
ular lesions [4,5], and possibilities remain that this prop-
erty should restrict the general applicability of ENU
mutagenesis.
While phenotype-based mutagenesis screens have been
effective in obtaining a variety of phenotypic mutants [6],
ENU mutagenesis has recently been extended to gene-
driven analyses of the mouse genome aimed at producing
allelic series of functional mutations at particular loci [7-
14]. The sequence-based approach is also suited for ana-
lyzing the mechanisms of mutation, as it should identify
any sequence changes induced within the targeted
regions, thereby allowing a precise evaluation of the true
mutational pattern. To gain a more comprehensive under-
standing of the mutational bias inherent in ENU muta-
genesis, this article describes a detailed examination of the
pattern of induced DNA sequence changes recently
obtained from our sequence-based screen of ENU-muta-
genized mice using a temperature gradient capillary elec-
trophoresis (TGCE) system [13]. Our aim here is four-
fold: (i) to estimate the frequency per nucleotide site of
ENU-induced mutation; (ii) to see if there is any indica-
tion of strand-specific pattern of induced mutation; (iii)
to contrast the mutational patterns in phenotype- versus
sequence-based mutagenesis screens; and (iv) to infer the
spectrum of amino acid changes obtained by ENU muta-
genesis screens. The new data provided by the present
analysis will be of great use in promoting the efficient pro-
duction of murine models for human genetic disorders.
Moreover, it will also expand our understanding of molec-
ular mechanisms of mutagenic processes, which are the
underpinnings of any comparative and evolutionary
genomic data.
Results and discussion
Site-specific pattern and frequency of induced mutations
Whereas our mutagenesis screen includes nongenic por-
tion of the mouse genome [13], the present analysis
focuses on the sequence changes identified within the
protein-coding genes (or more specifically, mutations
detected in exonic as well as flanking intronic or promoter
regions) so that the detected mutations are classified as
base changes on the nontranscribed (i.e. sense) strand.
Excluding those mutations detected in the intergenic
sequences, we have identified, by scanning a total of
181,031,647 nucleotide sites, 131 unique germline muta-
tions, which include 130 base replacement changes as
summarized in Table 1; the remainder is a length muta-
tion that deletes a cytosine site on the nontranscribed
strand. The overall frequency of base replacement muta-
tion is therefore obtained as 7.18 × 10-7 per nucleotide site
per generation. (Inclusion of mutations detected in inter-
genic sequences yields a slightly higher rate of 7.49 × 10-7
[13].) Based on a preliminary experiment utilizing Taq
polymerase-induced errors as positive controls, we deter-
mined that under the experimental conditions used in our
mutation screening [13], the rate of mutation discovery by
our TGCE system was ~50%; the absolute rate of ENU-
induced heritable mutation is therefore estimated roughly
as 1.4 × 10-6 per nucleotide site, which is approximately
two orders of magnitude higher than the spontaneous
mutation rate in humans (~2 × 10-8 per site per generation
[15-17]). The detail of the control experiment will be pub-
lished elsewhere.
Table 1 also shows that in accord with the previous obser-
vations [1,18], ENU preferentially introduced heritable
changes at T/A sites. In contrast, only a single instance of
G-to-C transversion was recorded, while C-to-G transver-
sion was not detected at all. Although there are several
reported instances of putatively ENU-induced G/C-to-C/
G changes (e.g. [7,11,19,20]), we suspect that those muta-
tions are in fact spontaneous.
Our collection of ENU-induced mutations further sug-
gests that the mutation frequency at thymines on the non-
transcribed strand is substantially higher than the
frequency at adenines (11.92 versus 6.05 mutations
Table 1: Frequency of base replacement changes in the 
sequence-based screen
Base change
From To k L µ × 107 (95%CI)
T C 31 6.49 (4.58 – 9.21)
A 21 4.39 (2.88 – 6.72)
G 5 1.05 (0.46 – 2.44)
Subtotal 57 47,799,305 11.92 (9.21 – 15.45)
C T 18 4.24 (2.69 – 6.70)
A 6 1.41 (0.66 – 3.07)
G 0 0.00 (0.00 – 0.71)
Subtotal 24 42,475,136 5.65 (3.81 – 8.41)
A T 8 1.73 (0.89 – 3.40)
C 2 0.43 (0.13 – 1.56)
G 18 3.89 (2.47 – 6.14)
Subtotal 28 46,311,939 6.05 (4.20 – 8.74)
G T 6 1.35 (0.63 – 2.94)
C 1 0.22 (0.05 – 1.25)
A 14 3.15 (1.89 – 5.29)
Subtotal 21 44,445,267 4.72 (3.10 – 7.22)
Total 130 181,031,647 7.18 (6.05 – 8.53)
Mutations are viewed as base changes on the nontranscribed strand.Page 2 of 10
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(CIs) do not overlap with each other, suggesting that the
observed strand asymmetry is not due merely to chance
events but instead reflects the true nature of strand-spe-
cific mutagenic mechanisms; heritable changes are pre-
dominantly introduced at T/A base pairs when thymines
are located on the nontranscribed strand (χ2df = 1 = 9.001,
P = 0.003). Strand-specificity was not detected among
changes at G/C pairs (5.65 versus 4.72 mutations among
107 sites; χ2df = 1 = 0.359, P = 0.549). The possible cause of
the mutational asymmetry will be discussed later in this
section.
Consequences of ENU mutagenesis on amino acid 
sequences
Since the distribution of ENU-induced base replacement
changes (as described in Table 1) is markedly different
from the pattern of spontaneous mutation [15-17], the
utility of mouse ENU mutagenesis in recovering disease-
causing variants may somehow be limited, solely because
it produces a particular class of amino acid changes more
effectively than others. To see if the skewed distribution of
ENU-induced mutation should lead to biased generation
of amino acid variants, we here compute the expected dis-
tribution of amino acid replacement changes in the ENU-
mutagenized mouse proteome, as detailed in the Methods
section below.
Among 420 (= 21 × 20) types of amino acid replacement
changes (including those involving termination codons),
170 are possible through single base replacement,
whereas other changes necessarily require multiple muta-
tional steps. By combining the per-site frequency of ENU-
induced base replacement mutation (Table 1) with the
pattern of codon usage in the mouse coding sequences
[21], the relative frequencies of the 170 possible amino
acid changes were obtained as shown in Table 2, where
the expected count of each change among 1,000 nonsyn-
onymous mutations is listed. Expected proportion of syn-
onymous versus nonsynonymous changes for each amino
acid was also obtained as summarized in Table 3, which
shows that for certain amino acids (e.g. alanine, glycine,
and proline), more than 40% of induced base replace-
ment mutation result in synonymous changes. Overall, it
is found that 71.5% of base replacement mutations would
result in nonsynonymous changes (67.4% missense,
3.9% nonsense, and 0.2% make-sense), while the remain-
ing 28.5% would lead to synonymous changes that do not
alter amino acid sequences. As we shall see below, this
theoretical prediction is highly concordant with the
observed pattern of synonymous and nonsynonymous
mutations in the sequence-based screens.
An obvious consequence of ENU mutagenesis is that
because of the relatively low occurrence of G/C-to-C/G
transversion changes (Table 1), some amino acid replace-
Table 2: Expected frequency of amino acid replacement changes
To
From Ala Arg Asn Asp Cys Gln Glu Gly His Ile Leu Lys Met Phe Pro Ser Thr Trp Tyr Val X Total
Ala * 4.4 2.1 0.0 1.0 6.3 14.6 19.7 48.3
Arg * 4.1 3.6 6.2 3.0 1.1 2.8 5.0 1.1 0.5 4.3 0.4 4.4 3.3 39.7
Asn * 9.5 1.1 4.2 7.6 9.5 1.1 4.2 37.0
Asp 1.4 10.1 * 10.3 12.5 0.7 4.3 5.5 44.9
Cys 10.1 * 1.6 2.1 7.2 0.8 4.9 4.4 31.2
Gln 12.0 * 0.0 5.3 5.3 4.4 1.3 13.1 41.5
Glu 1.9 8.2 1.0 * 17.5 14.2 7.8 6.1 56.7
Gly 1.0 7.8 7.0 3.0 6.8 * 7.0 1.4 5.9 1.5 41.6
His 6.7 2.4 0.0 5.2 * 3.0 0.7 7.3 25.4
Ile 0.5 11.4 * 2.2 2.1 3.0 4.5 2.7 19.9 11.9 58.0
Leu 5.7 14.2 9.9 5.9 * 7.7 11.9 35.6 8.7 0.9 1.4 6.3 108.3
Lys 14.6 6.8 1.6 14.6 2.5 * 4.0 1.6 6.5 52.2
Met 1.6 7.3 3.3 6.8 * 10.0 6.0 35.1
Phe 2.8 11.6 25.4 * 17.1 11.6 2.8 71.1
Pro 0.0 0.0 2.2 3.5 17.2 * 17.2 5.7 45.8
Ser 3.5 7.4 6.8 3.7 8.4 2.9 4.5 9.8 21.9 * 15.3 0.0 3.3 1.5 89.1
Thr 14.2 0.0 3.1 13.9 2.1 1.6 1.6 6.3 * 42.9
Trp 9.1 1.3 0.9 1.1 0.2 * 5.2 17.8
Tyr 8.4 2.0 7.4 12.4 3.3 0.8 * 6.0 40.4
Val 27.3 7.8 10.7 4.4 7.1 4.2 6.1 2.4 * 70.0
X 0.9 0.2 0.6 0.1 0.1 0.3 0.4 0.1 0.5 0.2 * 3.2
Total 49.4 76.5 49.0 38.8 22.5 28.5 44.7 51.6 35.9 56.5 69.4 42.5 23.5 33.9 62.7 87.3 68.6 8.0 35.7 61.0 54.0 1000.0
Frequencies are adjusted so as to give the expected number of changes per 1,000 nonsynonymous mutations. Blanks correspond to amino acid 
replacements that require multiple mutational steps. An X designates termination codons, whereas asterisks (*) indicate synonymous changes.Page 3 of 10
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(Table 2). As long as the expectation is based on the
present collection that does not include any C-to-G trans-
versions (see Table 1), it is suggested that seven of the
amino acid changes should never be produced by ENU
treatment (zero entries in Tables 2 and 3). Likewise, other
seven amino acid replacements that are possible only by
G-to-C transversions would be detected only in a rare
occasion. While these two classes of mutation represent
nearly 5% of disease-associated amino acid replacement
changes observed in humans [22], they would comprise
only 0.48% of the entire set of ENU-induced amino acid
replacement changes. This imbalance suggests that a pre-
cise understanding of the mutational pattern and fre-
quency of ENU-induced nucleotide changes would be
desirable for properly designing and conducting a
sequence-based mutagenesis experiment.
Contrasting mutational patterns in phenotype- versus 
sequence-based screens
To see whether a similar pattern of biased mutation could
also be detected in phenotype-based mutagenesis screens,
we here contrast two classes of induced mutations, each
derived from phenotype- and sequence-based screens,
respectively. Previously, Justice et al. [1] provided a list of
germline mutations detected in phenotype-based screens
of ENU-mutagenized mice (see also [18]). Among 62
mutations recorded in Justice et al. [1], two mutations
(816SB and 4494SB at the Myo7a locus) accompany dele-
tions [23], while other two (b-m3H and b-m4H at the Gpi1
locus) are considered to have originated from a single
mutational event [24]. Hence 59 mutations are relevant
for the present analysis. By reviewing the literature that are
not included in Justice et al. [1], we have collected another
218 base replacement changes identified in phenotype-
based screens, yielding a total of 277 ENU-induced germ-
line mutations at 143 loci distributed across the 19 auto-
somes as well as the X chromosome in the mouse. The
complete list of the relevant literature is provided as a sup-
plementary material [see Additional file 1].
At first, it may appear that the overall pattern of germline
mutations detected in phenotype-based screens is similar
to the corresponding pattern in our sequence-based
screen (Table 4); induced changes are found predomi-
nantly at T/A sites (75.1%). Moreover, whereas mutations
at G/C sites show no clear sign of strand-specific effects
(30 mutations at guanines versus 39 at cytosines on the
nontranscribed strand), mutational changes at T/A sites
occur more frequently when thymines and not adenines
are located on the nontranscribed strand (136 versus 72).
Whether the mutational pattern in phenotype-based
screens should truly reflect the underlying distribution of
ENU-induced mutations, however, still awaits further
consideration.
While it is expected that the mutational skew detected in
our sequence-based screen (Table 1) is a faithful manifes-
Table 3: Amino acid-specific pattern of synonymous and nonsynonymous changes
To
From Ala Arg Asn Asp Cys Gln Glu Gly His Ile Leu Lys Met Phe Pro Ser Thr Trp Tyr Val X
Ala 41.9 5.3 2.6 0.0 1.3 7.6 17.6 23.7
Arg 35.0 6.7 5.9 10.1 5.0 1.7 4.7 8.2 1.8 0.8 7.1 0.6 7.2 5.3
Asn 25.5 19.0 2.1 8.5 15.4 19.0 2.1 8.5
Asp 2.2 16.4 27.3 16.7 20.2 1.2 7.0 9.0
Cys 25.6 21.0 4.1 5.3 18.3 2.0 12.4 11.2
Gln 23.2 19.9 0.0 10.3 10.3 8.4 2.6 25.3
Glu 2.7 11.3 1.4 21.5 24.2 19.7 10.8 8.4
Gly 1.4 11.0 9.9 4.3 9.6 41.3 9.9 2.0 8.4 2.2
His 19.5 7.1 0.0 15.3 25.9 8.7 2.2 21.3
Ile 0.6 14.4 26.6 2.7 2.7 3.7 5.6 3.4 25.1 15.1
Leu 3.4 8.4 5.8 3.5 36.1 4.6 7.0 21.0 5.1 0.6 0.8 3.7
Lys 22.4 10.4 2.5 22.4 3.9 19.8 6.1 2.5 10.0
Met 4.6 20.8 9.5 19.4 28.6 17.1
Phe 3.2 13.6 29.9 16.2 20.1 13.6 3.2
Pro 0.0 0.0 2.9 4.6 22.4 40.2 22.4 7.5
Ser 2.8 5.9 5.4 3.0 6.7 2.3 3.6 7.7 17.4 29.3 12.1 0.0 2.6 1.2
Thr 20.5 0.0 4.5 20.0 3.0 2.4 2.3 9.1 38.2
Trp 50.9 7.4 4.9 6.3 1.1 29.5
Tyr 16.7 4.0 14.8 24.7 6.6 1.6 19.8 11.9
Val 28.2 8.0 11.1 4.6 7.4 4.4 6.3 2.5 27.6
X 23.1 4.6 14.3 2.3 2.2 6.7 9.7 1.4 12.2 4.2 19.2
Expected proportions of synonymous versus nonsynonymous changes, conditional on a base replacement mutation within a given amino acid site, 
are indicated in percentile. Blanks correspond to changes that require multiple mutational steps. An X designates termination codons. Expected 
proportions of synonymous changes are indicated in italics.Page 4 of 10
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mutation, the mutational pattern in phenotype-based
screens (Table 4) may be confounded by several addi-
tional factors, including (i) unknown nucleotide compo-
sition of the genomic regions that are the potential target
of the mutagenesis, and (ii) differential phenotypic effects
caused by different base replacement mutations. These
factors do not affect the mutational pattern in the
sequence-based screens (although it may still be con-
founded due to nonrandom mutation discovery by the
TGCE system, which we consider unlikely). For one rea-
son, this is because the per-site mutation frequencies
derived from the sequence-based analysis are, by defini-
tion, adjusted by the nucleotide composition of the tar-
geted regions. Such adjustments are possible only when
we base our analysis on appropriate sequence informa-
tion, which is usually never obtained in the phenotype-
based analysis. Moreover, while only those mutations that
confer noticeable effects on the focal phenotype can be
identified by phenotype-based screens, any mutational
changes that fall within the targeted regions should in
principle be identified by sequence-based screens, irre-
spective of their phenotypic effects. The former may hence
represent a biased set of the latter, comprising a limited
class of mutations that potentially has greater impacts on
phenotypic function. Put differently, this implies that by
investigating the incongruence between the two classes of
mutations, we may be able to specify mutations with
higher propensities of disrupting genome function.
As a possible sign of such incongruence, we here focus on
a statistically significant difference detected for the pat-
terns of mutational changes at thymines. In our sequence-
based screen (Table 1), 57 mutations are found to alter
thymines on the nontranscribed strand, among which 31
is replaced by cytosines, while 21 by adenines. Contrast-
ingly, among 136 detected changes at thymines in the
phenotype-based screens (Table 4), 76 are replaced by
adenines, while only 47 result in replacement by cytosines
(χ2df = 1 = 6.778, P = 0.009). Similar discrepancy between
the two classes of mutations has been also pointed out by
Augustin et al. [11]. Since T-to-A mutations may generate
nonsense changes whereas T-to-C mutations do not, the
excess of T-to-A mutations in phenotype-based screens
may be because of the greater impact of nonsense changes
on protein function. At first glance, this conjecture may
appear valid, since nonsense changes are disproportion-
ately overrepresented among mutations detected in phe-
notype-based screens (Table 5); among those mutations
identified in the protein-coding sequences (i.e. synony-
mous and nonsynonymous mutations), only 4.6% (3/65)
are nonsense in our sequence-based screen (in reasonable
agreement with the theoretical expectation of 3.9%; see
above), whereas in the phenotype-based screens, the cor-
responding proportion exceeds 20% (46 among 223
mutations). However, a closer look at the two classes of
mutations unveils that the incongruence is also present
even when only missense mutations are considered (Table
6). Since different subsets among the possible amino acid
replacements are achieved by different base replacement
changes, this observation suggests that amino acid
replacements induced by T-to-A mutations are expected to
affect protein function more radically on average, eventu-
ally leading to their excess representation in phenotype-
based screens.
Table 4: Reported number of base replacement changes in ENU mutagenesis
Base change Phenotype- based screens Sequence-based screens
From To Germ cells a ES cells
T C 47 (17.0) 12 (14.5) 3 (9.7)
A 76 (27.4) 15 (18.1) 4 (12.9)
G 13 (4.7) 1 (1.2) 3 (9.7)
C T 21 (7.6) 5 (6.0) 9 (29.0)
A 16 (5.8) 4 (4.8) 1 (3.2)
G 2 (0.7) 0 (0.0) 2 (6.5)
A T 24 (8.7) 6 (7.2) 0 (0.0)
C 7 (2.5) 1 (1.2) 0 (0.0)
G 41 (14.8) 18 (21.7) 5 (16.1)
G T 10 (3.6) 12 (14.5) 1 (3.2)
C 0 (0.0) 1 (1.2) 0 (0.0)
A 20 (7.2) 8 (9.6) 3 (9.7)
Total 277 (100.0) 83 (100.0) 31 (100.0)
Mutations are viewed as base changes on the nontranscribed strand. The relative proportion (in percentile) of each change is indicated in the 
parenthesis. 
a Germline mutations detected in Sakuraba et al. [13] are not included.Page 5 of 10
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induced germline mutations detected independently in
other sequence-based mutagenesis screens [7-10,12,14],
as well as of mutations detected in sequence-based screens
of ENU-mutagenized ES cells [20,25]. (Mutations
described in Augustin et al. [11] are not included because
the base changes on the nontranscribed strand are not
specified.) While the overall patterns may appear similar,
they do not show a clear sign of mutational bias peculiar
to our sequence-based screen (more T-to-C transition
than T-to-A transversion mutations). Hence although we
expect that different screening methods should identify
distinct sets of induced changes, possibilities remain that
other factors not discussed here further complicate the
patterns of mutations detected in mutagenesis screens.
Possible causes of the strand asymmetry
To account for the observed strand bias among mutations
induced at T/A sites (Table 1), we here discuss the possi-
bility that the mutational asymmetry is generated as a by-
product of transcription-coupled repair (TCR) of DNA
damages. The process of TCR has been considered as a
candidate responsible for the compositional strand asym-
metries in the transcribed portion of the mammalian
genome [26-32].
Transcription overexposes the nontranscribed strand to
DNA damage, thereby biasing the occurrence of muta-
tions between the two strands. Based on comparative
analyses of orthologous sequences, it has recently been
hypothesized that the compositional asymmetries in
mammalian transcribed regions are indeed caused by the
mutational bias inherent in TCR [26]. Despite some criti-
cisms (e.g. [33]), the hypothesis has gained a further sup-
port from comprehensive analyses of human gene
expression, which have detected a significant and positive
correlation between the extent of compositional asymme-
try and the expression level in the germline [28,31,32].
If TCR indeed plays a major part in generating the compo-
sitional strand asymmetries in the mammalian genome,
then it should also affect the strand-specific pattern of
experimentally induced mutation in a predictable man-
ner. As reported previously [4,5], ENU introduces herita-
ble sequence changes predominantly at T/A sites by
adding O2- or O4-ethyl adducts on thymines. Conse-
quently, if transcription-associated DNA repair mecha-
nisms (such as TCR) should effectively remove molecular
lesions on the transcribed but not on the complementary
nontranscribed strand of DNA, the resulting pattern of
mutations on the nontranscribed strand should be
strongly skewed toward changes at thymines; adenine
modifications, on the other hand, should be less fre-
quently observed.
Based on a genome-wide set of heritable mutations
obtained from our sequence-based screen, the present
study clearly demonstrates that ENU-induced changes in
the mouse germline indeed follow the predicted pattern
(Table 1). Although similar observations have been made
for induced changes at the Hprt locus [34-36], previous
reports are based on somatic mutations isolated from
phenotypic assays using 6-thioguanine as the selective
chemical agent; namely, the mutations are not heritable
and the screening methods are not sequence-based. Esti-
Table 6: Mutation types in phenotype- versus sequence-based 
screens
Phenotype-based screens Sequence-based screen a
Mutation type T-to-C T-to-A T-to-C T-to-A
Missense 31 48 12 5
Make-sense 0 1 0 0
Nonsense 0 18 0 2
Synonymous 0 0 3 0
3' 
untranslated 
region
0 0 1 0
Intronic b 16 9 15 14
Total 47 76 31 21
The number of T-to-C or T-to-A changes for each type of mutation is 
listed.
a Only mutations detected in Sakuraba et al. [13] are included.
b Intronic mutations include base replacement changes leading to 
aberrant splicing.
Table 5: Mutation types in ENU mutagenesis
Phenotype-
based screens
Sequence-based screens
Mutation type Present 
study
Germ 
cells a
ES 
cells
5' flanking 0 1 1 0
Exonic
5' untranslated region 2 0 1 0
Missense 175 44 45 18
Make-sense 2 1 1 0
Nonsense 46 3 4 0
Synonymous 0 17 15 9
3' untranslated region 0 1 2 0
Intronic b 52 63 8 4
Not specified 0 0 6 0
Total 277 130 83 31
The number of occurrence for each type of mutation is listed.
a Germline mutations detected in Sakuraba et al. [13] are not 
included.
b Intronic mutations include base replacement changes leading to 
aberrant splicing.Page 6 of 10
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composition of the targeted regions either. Therefore, pos-
sibilities cannot be excluded that the observed mutational
pattern may have been confounded by the region-specific
nucleotide composition, and also by the phenotypic
effects of induced changes. As detailed above, these factors
are adequately controlled in the present analysis.
While premutagenic lesions including O6- and N7-ethyl-
guanines are formed at even higher rates in vivo by ENU
[37], these DNA damages are repaired rather rapidly by
mechanisms other than TCR [4,5], eventually making
only a minor contribution to heritable changes. The
absence of mutational bias at G/C sites (Table 1) may fur-
ther lend support for the view that TCR, and not the other
transcription-associated mutagenic mechanisms such as
cytosine deamination [38,39], is the primary cause of
compositional asymmetries in the mammalian tran-
scribed regions [26]. Moreover, since some forms of DNA
repair eliminate lesions by preferentially killing the dam-
aged cells [40], the selective removal of the lesions on the
transcribed strand may be promoted by the apoptotic
effect of strand-specific repair mechanisms.
The strand-specific effects of TCR should be observed
among heritable mutations only when mutated nucle-
otide sites are transcribed in the germline. In other words,
strand asymmetry would not be observed when muta-
tions are induced in the nontranscribed portion of the
genome, which might include intergenic sequences and
pseudogenes. (A caveat here is that some pseudogene
sequences retain transcriptional activity while loosing
their primary ability of encoding amino acid sequences
[41-44].) Alternatively, it is also expected that the strand-
specific mutational pattern should be absent in genic
regions if they are coupled with antisense transcripts
[45,46]. When genes and their antisense products are
coexpressed [47], transcription-associated effects should
influence both sense and antisense strands equally,
thereby erasing the vestiges of strand-specific effects.
Although we have not experimentally confirmed the tran-
scription status in the mouse germ cells of the 54 genic
regions screened in our analysis, available data retrieved
from the mouse Gene Expression Database (GXD) [48]
suggest that in testis, 17 regions are transcribed, whereas
none has been demonstrated to be nontranscribed; for the
remaining 37 regions, no appropriate information cur-
rently exists. The genomic regions included in our
sequence-based screen are chosen without any prior
knowledge for their function or expression status in the
germline. Recalling that some level of germline transcrip-
tion would involve a large fraction of human genes (71 –
91% [28]), we expect that most of the remaining 37
sequences are also transcribed in the mouse germ cells,
even if they may not be essential for germline function. By
contrasting the patterns of experimentally induced germ-
line mutations in genomic regions with distinct transcrip-
tional properties, we would gain a more clarified view for
the role of transcription in generating mutational and
eventual compositional strand asymmetries.
Conclusion
Based on a detailed evaluation of the screening data
obtained from our large-scale mutagenesis experiment,
the present analysis clearly illustrates the biased nature of
ENU-induced mutations, and discusses the possible
causes and consequences of the nonuniformity. Despite
the mutational bias inherent in ENU mutagenesis, how-
ever, this study also provides a strong support for its utility
in obtaining a series of allelic variants at a genetic locus.
We expect that the present findings will be useful in pro-
moting the efficient production of mutant lines harboring
amino acid variants. More generally, by enhancing the
collection of experimentally induced mutations in unam-
biguously defined genomic regions, sequence-based
mutagenesis studies will further illuminate the molecular
basis of mutagenic and repair mechanisms that preferen-
tially produce a certain class of mutational changes over
others.
Methods
Sequence-based mutagenesis screen
The detailed method of our sequence-based mutagenesis
is documented in Sakuraba et al. [13]. In brief, male
C57BL/6J mice were injected intraperitoneally with an
ENU dose of 85 or 100 mg/kg at 8–10 weeks of age. The
injections were carried out twice at weekly intervals. The
ENU-treated males were then mated to DBA/2J or C3H/
HeJ females to obtain G1 offspring, which should harbor
ENU-induced mutations as heterozygotes. We have cho-
sen 63 genomic regions (54 genic and nine putatively
intergenic) for the target-selected mutagenesis and
designed 199 primer pairs therein (see Table 1 in [13]).
Most of the primer pairs targeted for the genic sequences
were designed to cover exonic regions, which were aimed
at detecting induced mutations leading to amino acid
sequence alterations, while only a few extended to non-
transcribed flanking sequences. Heritable changes in the
G1 males were screened using a temperature gradient cap-
illary electrophoresis (TGCE) system, which eventually
summed up to a screen of nearly 2 × 108 nucleotide sites
in total [13].
Since we are interested in obtaining the strand-specific
pattern of induced changes, we here concentrate on muta-
tions identified in the 54 genic regions, where the two
strands of the genomic DNA can uniquely be discrimi-
nated (namely, sense versus antisense strands). By target-
ing more than 50 loci that together embrace all the 19Page 7 of 10
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free from locus- or region-specific effects that may obscure
the genuine pattern of ENU-induced mutation. The GC
content of the whole screened sites is 48.0% (see also
Table 1), which is somewhat lower than the averages for
the mouse exonic sequences (52.0 – 57.1% [49]), but well
above the genome-wide average of 42% in mice [50].
The detected mutations are classified according to nucle-
otide changes on the nontranscribed (or sense) strand.
Complementary mutations (e.g. A-to-T versus T-to-A
changes) are therefore distinguished and considered dif-
ferent from each other. Note that this distinction cannot
be made for sequence changes detected in nongenic
regions. The rare occasions of mutations producing length
variants (insertions and deletions) are also excluded from
the analysis.
Per-site frequency of induced mutations
Given the observed number kij for mutations from nucle-
otide i to j, (i, j ∈ {T, C, A, G}, j ≠ i), we compute the muta-
tion frequency per nucleotide site as µij = kij/Li, where Li
represents the total count of nucleotide i within the
genomic region covered in the screen. The average fre-
quency of mutation at nucleotide i is simply given by µi =Σjµij = Σjkij/Li. Likewise, the overall frequency of mutation
per nucleotide site is obtained as Σijkij/ΣiLi.
Assuming that the probability of observing k or fewer
mutations within L screened sites should follow a poisson
distribution P{X ≤ k} = Σkκ = 0 [e-Lµ (Lµ)κ /κ!] (where κ des-
ignates a dummy variable), we determine the 95% confi-
dence interval (CI) for the mutation frequency µ by
solving this equation with P = 0.025 and 0.975. When no
mutations were observed (as for the C-to-G transversion
in our collection; see Table 1), we solved the equation P{X
= 0} = e-Lµ = 0.05 to obtain an upper limit for the mutation
frequency.
Expected pattern of amino acid changes
To infer the effect of ENU mutagenesis on the mouse pro-
tein sequences, the expected pattern of amino acid
replacement changes is computed by superimposing the
distribution of ENU-induced base replacement mutations
onto the pattern of codon usage in the mouse coding
sequences. For each of the 64 triplet codons, there are nine
codons that could be reached by single base replacement.
The relative frequency distribution of 576 (= 64 × 9) pos-
sible codon replacements is obtained simply by multiply-
ing the abundance of the original codon in the mouse
coding sequences, as described in the Codon Usage Data-
base [21] based on GenBank Release 151.0 (19 December,
2005), by the per-site frequency of appropriate base
replacement mutation (as derived above). Base replace-
ment mutation in a codon is either synonymous or non-
synonymous; the latter leads to an amino acid sequence
alteration, while the former preserves the coded amino
acid despite the change in the DNA sequence. (Mutation
that preserves a termination codon (e.g. TAA-to-TAG) is
here considered as synonymous.) Nonsynonymous muta-
tion is further subdivided into missense (exchange of an
amino acid by another amino acid), nonsense (replace-
ment of an amino acid by a termination codon), or make-
sense (replacement of a termination codon by one of the
20 amino acids) mutation. The expected distribution of
amino acid replacement changes is obtained from the
derived pattern of codon replacement, by summing up the
appropriate codons in case of degeneracy. The result is
summarized in Table 2.
Literature survey
We carried out a comprehensive literature survey and col-
lected reported instances of ENU-induced base replace-
ment mutations detected in phenotype-based
mutagenesis screens. This has been done by adding germ-
line mutations that are not included in the previous list
[1,18]. We do not claim to have included all the relevant
studies, but we expect that the collection should represent
an unbiased sample of the literature. An additional litera-
ture survey has been conducted also for germline muta-
tions detected independently in other sequence-based
studies, as well as for mutations identified in mutagenized
embryonic stem (ES) cell systems.
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